• Globe Newswire

Every minute counts: EAACI calls for urgent action to make schools safe for children at risk of anaphylaxis

Globenewswire -

• Globe Newswire

Boehringer Ingelheim licenses novel oral therapeutics program for immune diseases from Sitryx Therapeutics

Globenewswire -

• Globe Newswire

EAACI Congress 2025 - Breaking Boundaries in Allergy, Asthma, and Clinical Immunology: Integrating Planetary Health for a Sustainable Future

Globenewswire -

• Globe Newswire

GEn1E Lifesciences appoints François Nader, MD as Chair of its Board of Directors

Globenewswire -

• Globe Newswire

BioMed X Launches New T Cell Immunology Discovery Platform